---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-001400"
form_type: "8-K"
ticker: "AYTU"
cik: "0001385818"
company_name: "AYTU BIOPHARMA, INC"
filed_at: "2023-01-05T23:59:59+00:00"
generated_at: "2026-06-20T19:28:58.802868+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aytu BioPharma enacts 1-for-20 reverse stock split to regain Nasdaq $1.00 bid compliance

## Summary
- 1-for-20 reverse split reduces outstanding shares from ~68.8M to ~3.4M.
- Company must maintain closing bid ≥$1.00 for 10 consecutive days by May 22, 2023 to comply with Nasdaq.
- Proportional adjustments to warrants, options, and equity plan pool; no fractional shares—cash in lieu.
- New CUSIP 054754858; shares continue trading under ticker AYTU on Nasdaq.

## SEC filing metadata
- accession: 0001104659-23-001400
- form_type: 8-K
- ticker: AYTU
- cik: 0001385818
- company_name: AYTU BIOPHARMA, INC
- filed_at: 2023-01-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1385818/000110465923001400/0001104659-23-001400-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1385818/000110465923001400/tm231530d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-001400
- JSON: https://secwatch.observer/filing/0001104659-23-001400.json
- Plain text: https://secwatch.observer/filing/0001104659-23-001400.txt

## Key facts
- Governance Changes
  AYTU BIOPHARMA, INC: Approved a 1-for-20 reverse stock split via a Certificate of Amendment to the Certificate of Incorporation, effective January 6, 2023 (effective 2023-01-06).
  - Change: charter amendment
  - Effective: 2023-01-06
  source text: On January 4, 2023, the Board of Directors of Aytu BioPharma, Inc. (“the Company” or “Aytu”) approved a 1-for-20 reverse stock split of the Company's common stock, which will be effective at 12:01 a.m. Eastern Time on Friday, January 6, 2023 pursuant to a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Certificate of Incorporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1385818/000110465923001400/0001104659-23-001400-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.